About Cough Remedies
Cough is one of the commonest symptoms of respiratory tract infections and is a frequent problem faced in general practice as well as in hospital practice. A various disease processes may present with cough and definitive treatment depends on identifying the cause and diagnosis. Particular treatment of the cause should control the cough, but this may not happen in all cases and in a sizeable proportion of patients, no associated cause can be found. An augmented sensitivity of the cough reflex can be observed in patients with dry cough. The global cough remedies market is expected to witness a significant growth owing to increase in geriatric population and growth in awareness about advanced medicine.
Attributes | Details |
---|
Study Period | 2020-2032 |
Base Year | 2024 |
Unit | Value (USD Million) |
Analyst at AMA Research estimates that United States and United Kingdom Players will contribute the maximum growth to Global Cough Remedies market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Johnson & Johnson (United States), Reckitt Benckiser Group Plc (United Kingdom), Bayer Ag (Germany), Glaxosmithkline Plc. (United Kingdom), AstraZeneca (United Kingdom), Pfizer Inc. (United States), Sanofi (France), Novartis Ag (Switzerland), Prestige Brands, Inc. (United States) and Procter & Gamble (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Merck & Co. (United States) and Sun Pharmaceutical Industries Ltd. (India).
Segmentation Overview
AMA Research has segmented the market of Global Cough Remedies market by Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics and Others) and Region.
On the basis of geography, the market of Cough Remedies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Switzerland, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Cough Remedies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Dosage Form, the sub-segment i.e. Oral Syrups will boost the Cough Remedies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Demand of Over-The-Counter Products
Market Growth Drivers:
Increase in Geriatric Population Across the Globe and Growth in Awareness About Advanced Medicine
Challenges:
Side Effects Related to Cough Remedies
Restraints:
Strict Government Regulations
Opportunities:
Development in R&D Activities Associated With Cough Remedies
Market Leaders and their expansionary development strategies
On February 21, 2019, Merck, known as MSD outside the United States and Canada, and Immune Design, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Design
The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. FDA is also requiring the addition of safety information about the risks of misuse, abuse, addiction, overdose, death, and slowed or difficult breathing to the Boxed Warning, our most prominent warning, of the drug labels for prescription cough and cold medicines containing codeine or hydrocodone
Key Target Audience
Manufacturers of Cough Drugs, Suppliers of Cough Remedies, Distributers of Cough Remedies, Healthcare industry, Governmental bodies and Research Firms
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.